Lupu Dale E, Aldous Annette, Anderson Elizabeth, Schell Jane O, Groninger Hunter, Sherman Michael J, Aiello Joseph R, Simmens Samuel J
Center for Aging, Health & Humanities, School of Nursing, George Washington University, Washington, DC.
Milken Institute School of Public Health, George Washington University, Washington, DC.
Am J Kidney Dis. 2022 May;79(5):699-708.e1. doi: 10.1053/j.ajkd.2021.08.019. Epub 2021 Oct 12.
RATIONALE & OBJECTIVE: Although guidelines recommend more and earlier advance care planning (ACP) for patients with chronic kidney disease (CKD), scant evidence exists to guide incorporation of ACP into clinical practice for patients with stages of CKD prior to kidney failure. Involving nephrology team members in addition to primary care providers in this important patient-centered process may increase its accessibility. Our study examined the effect of coaching implemented in CKD clinics on patient engagement with ACP.
Multicenter, pragmatic randomized controlled trial.
SETTING & PARTICIPANTS: Three CKD clinics in different states participated: 273 patients consented to participate, 254 were included in analysis. Eligible patients were 55 years or older, had stage 3-5 CKD, and were English speaking.
Nurses or social workers with experience in nephrology or palliative care delivered individualized in-person ACP sessions. The enhanced control group was given Make Your Wishes About You (MY WAY) education materials and was verbally encouraged to bring their completed advance directives to the clinic.
Primary outcome measures were scores on a 45-point ACP engagement scale at 14 weeks and a documented advance directive or portable medical order at 16 weeks after enrollment.
Among 254 participants analyzed, 46.5% were 65-74 years of age, and 54% had CKD stage 3. The coached patients scored 1.9 points higher at 14 weeks on the ACP engagement scale (β = 1.87 [95% CI, 0.13-3.64]) adjusted for baseline score and site. Overall, 32.8% of intervention patients (41 of 125) had an advance directive compared with 17.8% (23 of 129) of patients in the control group. In a site-adjusted multivariable model, coached patients were 79% more likely to have a documented advance directive or portable medical order (adjusted risk ratio, 1.79 [95% CI, 1.18-2.72]), with the impact principally evident at only 1 study site.
Small number of study sites and possible unrepresentativeness of the broader CKD population by study participants.
Individualized coaching may be effective in enhancing ACP, but its impact may be influenced by the health care environment where it is delivered.
The Patrick and Catherine Weldon Donaghue Medical Research Foundation, via the Greater Value Portfolio.
Registered at ClinicalTrials.gov with study number NCT03506087.
尽管指南建议为慢性肾脏病(CKD)患者提供更多且更早的预立医疗计划(ACP),但几乎没有证据可指导将ACP纳入肾衰竭前各期CKD患者的临床实践。在这个以患者为中心的重要过程中,除了初级保健提供者外,让肾病学团队成员参与进来可能会增加其可及性。我们的研究考察了在CKD诊所实施的指导对患者参与ACP的影响。
多中心、实用随机对照试验。
来自不同州的三家CKD诊所参与研究:273名患者同意参与,254名纳入分析。符合条件的患者年龄在55岁及以上,患有3 - 5期CKD,且讲英语。
有肾病或姑息治疗经验的护士或社会工作者进行个性化的面对面ACP课程。强化对照组被给予《了解您的愿望》(MY WAY)教育材料,并被口头鼓励将其完成的预立医疗指示带到诊所。
主要结局指标为入组14周时45分的ACP参与度量表得分,以及入组16周时有记录的预立医疗指示或便携式医疗指令。
在分析的254名参与者中,46.5%年龄在65 - 74岁之间,54%患有CKD 3期。经基线得分和研究地点调整后,接受指导的患者在14周时的ACP参与度量表得分高1.9分(β = 1.87 [95% CI,0.13 - 3.64])。总体而言,32.8%的干预组患者(125名中的41名)有预立医疗指示,而对照组患者为17.8%(129名中的23名)。在经研究地点调整的多变量模型中,接受指导的患者有记录的预立医疗指示或便携式医疗指令的可能性高79%(调整风险比,1.79 [95% CI,1.18 - 2.72]),这种影响主要仅在1个研究地点明显。
研究地点数量少,研究参与者可能无法代表更广泛的CKD人群。
个性化指导可能有效提高ACP,但其影响可能受实施该指导的医疗环境影响。
帕特里克和凯瑟琳·韦尔登·多纳休医学研究基金会,通过更大价值投资组合提供。
在ClinicalTrials.gov注册,研究编号为NCT03506087。